Abstract Three new aminocoumarin antibiotics, termed ferulobiocin, 3-chlorocoumarobiocin and 8Ј-dechloro-3-chlorocoumarobiocin, were isolated from the culture broth of a Streptomyces coelicolor M512 strain expressing a modified clorobiocin biosynthetic gene cluster. Structural analysis showed that these new aminocoumarins were very similar to clorobiocin, with a substituted 4-hydroxycinnamoyl moieties instead of the prenylated 4-hydroxybenzoyl moiety of clorobiocin. The possible biosynthetic origin of these moieties is discussed.
Introduction
Clorobiocin and coumermycin A 1 ( Fig. 1) are members of the family of aminocoumarin antibiotics. They are potent inhibitors of bacterial gyrase [1] and represent interesting starting compounds for the development of new antibacterial agents by genetic and mutasynthetic methods [2] .
By expression of the clorobiocin biosynthetic gene cluster in Streptomyces coelicolor M512, the antibiotic can be conveniently produced [3] . Clorobiocin contains a 3-dimethylallyl-4-hydroxybenzoyl moiety (Ring A) which is formed under involvement of the aromatic prenyltransferase CloQ. Inactivation of the structural gene cloQ leads to abolishment of clorobiocin production [4] . In order to generate a strain suitable for mutasynthesis experiments, we expressed a cloQ-defective gene cluster in the heterologous host S. coelicolor M512, and replaced the genuine amide synthetase gene of the clorobiocin biosynthesis, cloL ( Fig. 1) , with the similar couL from coumermycin biosynthesis. couL encodes for an enzyme with different substrate specificity to CloL [5, 6] . As expected, the cloQcloL-defective heterologous expression strain did not produce clorobiocin. Unexpectedly, however, introduction of couL into this strain resulted in the formation of three new aminocoumarin antibiotics.
In this paper, we report the isolation, structure elucidation and antibacterial activities of these three new antibiotics, termed ferulobiocin, 3-chlorocoumarobiocin and 8Ј-dechloro-3-chlorocoumarobiocin. The occurrence of these compounds has interesting implications for the current hypotheses on phenylpropanoid and aminocoumarin biosynthesis in Streptomycetes.
Materials and Methods
Strains and Plasmids S. coelicolor M512 was kindly provided by E. Takano (Groningen, Netherlands) and Janet White (Norwich, United Kingdom). The integrative cosmid clo-BG1 was described by Eustáquio et al. [3] .
The E. coli -Streptomyces shuttle vector pUWL201, containing the ermE* promoter [7] was used for the construction of the couL expression plasmid pMS91. Therefore, couL was amplified by PCR. A HindIII site was introduced before the start codon using primer cumG1 (5Ј-CCGCTGCCCAAGCTTGAGTGCCTC-3Ј). At the Cterimnus, an XbaI restriction site was introduced after the stop codon using primer cumG2 (5Ј-CGGGCAGGCTCTAGAACAGCACTC-3Ј). Bold letters represent the corresponding restriction sites. The resulted PCR fragment was digested with HindIII and XbaI and subsequently cloned into pUWL201 to give pMS91.
Modification of the cosmid clo-BG1, and stable integration into the genome of S. coelicolor M512, were carried out as described by Eustáquio et al. [3] . Transformation with the couL expression plasmid pMS91 was carried out as described by Kieser et al. [8] .
Fermentation and Preparative Isolation of New Antibiotics
The genetically engineered S. coelicolor M512 strain was pre-cultured for 2 days in YMG medium, for 2 further days in corn starch medium and subsequently for 8ϳ10 days in production medium as described previously [9] . Cultures were treated with petrol ether to remove lipids, and subsequently the antibiotics were extracted with ethyl acetate [9] .
Analytical HPLC was carried out on an Agilent Eclipse Purification by preparative HPLC was carried out on a Multosphere 120 RP18-5 column (5 m m, 250ϫ10 mm, C&S Chromatographie Service, Düren, Germany) at a flow rate of 2.5 ml/minute and the same gradient as for the analytical column.
Structure Elucidation
The isolated products were analyzed by 1 H-NMR spectroscopy and by ESI-MS.
1 H-NMR spectra were measured on an Avance 400 MHz spectrometer (Bruker, Karlsruhe, Germany), using CD 3 OD as solvent. The NMR data are shown in Table 1 .
Mass spectra of the purified compounds were obtained from a Finnigan TSQ Quantum instrument using positive electrospray ionisation (ESI) (electrospray voltage 3.8 kV; heated capillary temperature 320°C; sheath and auxiliary gas: nitrogen; sheath gas flow rate: 30.1 AU; aux gas flow rate: 12.0 AU). The mass spectra are shown in Table 2 .
For LC-MS analysis, a Nucleosil 120 RP ODS-column (8 m m, 2ϫ250 mm, Macherey-Nagel) and a gradient of acetonitrile in water (each containing 0.1% HCOOH) from 0 to 50% acetonitrile over 20 minutes were used (flow rate 0.2 ml/minute). The collision-induced dissociation (CID) spectra during the HPLC run were recorded with collision energy ϩ25 eV, collision gas argon, and collision pressure
1.0ϫ10
Ϫ3 torr (133 mPa).
Antibacterial Activities
The antibacterial activities of the new compounds were tested against Bacillus subtilis ATCC 14893 in a disc diffusion assay as described previously [9] . Authentic clorobiocin was used as comparison. The activities were quantified from inhibition zone diameters and expressed relatively to clorobiocin.
Results

Detection and Isolation of the New Aminocoumarin Antibiotics
In cosmid clo-BG1, which harbours the complete biosynthetic gene cluster of clorobiocin, the genes cloQ and cloL were inactivated by l RED-mediated recombination [10] using previously described methods for the successive deletion of both genes [11] . Subsequently, this modified cosmid was heterologously expressed in S. coelicolor M512 [3] . The amide synthetase gene couL of the coumermycin biosynthetic gene cluster was cloned into the Streptomyces expression vector pUWL201 [7] and introduced into the mutant by protoplast transformation as described previously [12] . When the resulting strain was cultivated as described in the Experimental, the formation of three aminocoumarin antibiotics was observed. The same compounds were observed as side products in later mutasynthesis feeding experiments using the same strain (data not shown). The new compounds were extracted from the culture broth, isolated by reversed-phase HPLC and investigated by spectroscopic methods.
Structure Elucidation Ferulobiocin
The ESI-MS spectrum of this compound showed an [MϩH] ϩ ion at m/zϭ685. Furthermore, the spectrum showed the same characteristic fragments of the deoxysugar moiety (m/zϭ282) and the 5-methylpyrrole-2-carbonyl moiety (m/zϭ108) as observed for clorobiocin. However, while the mass spectrum of clorobiocin shows a fragment at m/zϭ189, representing the prenylated 4-hydroxybenzoyl moiety (ϭRing A), and a fragment at m/zϭ416, representing the moiety comprising both the aminocoumarin and the prenylated 4-hydroxybenzoyl moieties (see Fig. 1 and data obtained from commercially available ferulic acid showed that these NMR signals are in perfect agreement with those of ferulic acid (ϭ3-methoxy-4-hydroxycinnamic acid) and its corresponding esters, and the observed mass spectrometric data were also consistent with the presence of a feruloyl moiety.
Therefore, this new antibiotic represented a clorobiocin derivative containing a feruloyl moiety instead of the prenylated 4-hydroxybenzoyl moiety. This compound was termed ferulobiocin.
3-Chlorocoumarobiocin
The ESI-MS spectrum of the second compound showed an [MϩH] ϩ ion at m/zϭ689, in contrast to ferulobiocin (m/zϭ685). Consistently, the ion assigned to the acyl moiety appeared at m/zϭ181 (ferulobiocin: m/zϭ177). Otherwise, the spectrum showed the same characteristic peaks of the deoxysugar moiety and the 5-methylpyrrole-2-carbonyl moiety (m/zϭ282 and 108, respectively) as found in the spectra of ferulobiocin and clorobiocin. The 1 H-NMR spectrum of this compound showed the signals derived from the substituted deoxysugar and the aminocoumarin moieties, identical to these of clorobiocin and ferulobiocin (Table 1) . Very similar to the 1 H-NMR spectrum of ferulobiocin, two doublets at dϭ7.49 ppm (1H, 15.6 Hz) and d ϭ6.71 ppm (1H; 15.6 Hz) indicated the presence of two vinylic protons and the signals at dϭ7.56 (br s, 1H), 7.36 (d, 1H) and 6.92 ppm (d, 1H) again showed the presence of a 1,3,4-trisubstituted aromatic ring. However, in contrast to ferulobiocin, the singulett of the methoxygroup at d ϭ3.90 ppm (3H) was missing, and no other proton signal was found instead. This suggested that at position 3, the methoxygroup (31 Da) had been replaced by a chlorine atom (35 Da). Therefore, the new compound could be identified as a clorobiocin derivative containing 3-chloro-4-hydroxycinnamic acid instead of the genuine prenylated 4-hydroxybenzoyl moiety. This compound was termed 3-chlorocoumarobiocin.
8Ј-Dechloro-3-chlorocoumarobiocin
The ESI-MS spectrum of the third compound showed an [MϩH] ϩ ion at m/zϭ655, i.e. 34 dalton less than that of 3-chlorocoumarobiocin, corresponding to the loss of a chlorine atom. However, both the 1 H-NMR spectrum and the mass spectrum still showed the same signals derived from the 3-chloro-4-hydroxycinnamoyl moiety (Tables 1  and 2 ). In contrast, the 1 H-NMR spectrum now showed significant changes for the protons of the aminocoumarin ring (Table 1) , proving the presence of three rather than two protons (dϭ7.03 ppm, 2H; dϭ7.92 ppm, 1H). Exactly the same signals had been observed previously for aminocoumarin derivatives lacking the chlorine atom at position 8Ј [16] . Therefore, this compound differed from 3-chlorocoumarobiocin by lacking the chlorine atom at position 8Ј of the aminocoumarin ring.
Dependence of the Formation of Ferulobiocin, 3-Chlorocoumarobiocin and 8-Dechloro-3-chlorocoumarobiocin on the Presence of CouL
As mentioned above, the three new aminocoumarin antibiotics were found in a S. coelicolor M512 strain expressing a modified (i.e. cloQcloL-defective) clorobiocin cluster and additionally the amide synthetase gene couL. However, these products were not observed in strains not expressing CouL.
The amide synthetase CouL could not be replaced by CloL, which catalyzes a very similar reaction but has a different substrate specificity [5, 6] , since in a cloQdefective strain with intact cloL [9] , we could not detect the three new antibiotics described here, even upon specific examination with sensitive LC-MS techniques. However, CouL could be replaced by SimL of simocyclinone biosynthesis [17] , cloned into expression vector pUWL201, as is consistent with the reported substrate specificity of SimL.
Antibacterial Activities
The antibacterial activities of the three new compounds were determined by an agar diffusions test against B. subtilis (Table 3 ). All three compounds showed antibacterial activity, but clearly less than the very potent clorobiocin. 8Ј-Dechloro-3-chlorocoumarobiocin was less active than the two other compounds. This is consistent with earlier observations, which showed 80ϳ90% loss of antibacterial activity when the chlorine was removed from position 8Ј of the aminocoumarin antibiotics [16, 18] .
Discussion
In this study, we have generated a S. coelicolor M512 strain expressing a modified clorobiocin biosynthetic gene cluster, defective in an essential gene for the biosynthesis of Ring A of clorobiocin. We have additionally expressed a heterologous amide synthetase, CouL. We previously identified that this amide synthetase has a remarkably broad substrate specificity, accepting not only different pyrrole dicarboxylic acids as substrates, but also Ring A of clorobiocin, and analogs thereof [5, 6] . As discussed Relative bioactivities were estimated by comparing inhibition zones with those obtained for clorobiocin.
previously [6, 19] , this is in agreement with the hypothesis that couL may have evolved from an acestral gene very similar to cloL. We intended to use this strain for mutasynthesis experiments, i.e. for the external addition of various Ring A analogs, similar to a previous series of experiments by our group [5] .
To our surprise we found that our strain formed modified aminocoumarin antibiotics even without the addition of any Ring A analogs. Isolation and structural elucidation of these compounds showed that they were clorobiocin analogs containing substituted coumaroyl moieties instead of the prenylated 4-hydroxybenzoyl moiety. The latter moiety can only be formed in the presence of active CloQ. The three new aminocoumarin antibiotics described here have not been reported in the literature before.
The new compounds were observed in cloQ-defective strains expressing the heterologous amide synthetase CouL, but not in a previously generated cloQ-defective strain expressing CloL [4, 9] . This is consistent with the substrate specificities of CloL and CouL, since CouL but not CloL is capable of accepting substituted cinnamic acid substrates.
The fact that coumaric acid derivatives were formed in our strain was a surprise. The biosynthetic pathway to clorobiocin is known in detail [20] and does not involve coumaric acid derivatives. Neither have such compounds been described from S. coelicolor.
Coumaric acid derivatives belong to the most abundant biomolecules on earth, since they form part of lignin in plants. In Actinomycetes, however, these compounds are relatively rare, and only recently it was demonstrated that several Actinomycetes possess phenylalanine ammonialyase (PAL) and tyrosine ammonia-lyase (TAL) genes for the biosynthesis of cinnamic and coumaric acid [21, 22] . However, neither in the biosynthetic gene cluster of clorobiocin, nor in the completely sequenced genome of S. coelicolor, PAL or TAL genes have been described so far.
The host strain utilized in this study, S. coelicolor M512, is a derivative of S. coelicolor A3(2) [23] . Our present findings stimulated us to re-examine the genome sequence of S. coelicolor [24] . Blast search revealed one gene with 32% identity to the tyrosine ammonia-lyase Sam8 of Saccharothrix espanaensis [21] . This gene, SCO4932, is currently annotated as histidine ammonia-lyase. It remains to be shown whether it is involved in the formation of coumaric acid derivatives observed in this study.
Interestingly, we also detected two chlorinated compounds apparently derived from a 3-halogenation of 4-coumarate or tyrosine. The halogenase of clorobiocin biosynthesis, Clo-hal [12] , may be involved in the formation of these two compounds. So far, the genuine substrate of Clo-hal is unknown. However, also the genome of S. coelicolor contains a gene (SCO1275) with very high similarity to FAD-dependent halogenases [25] .
When various Ring A analogs were externally added to our strain, the three new compounds described here were commonly detected as side products, besides the clorobiocin analogs derived from incorporation of the added precursors (data not shown). Often the yields of the three compound described here were even higher than without external feeding, possibly due to the induction of enzymes of clorobiocin biosynthesis. Our study exemplifies that mutasynthesis experiments may result in the formation of unexpected compounds and therefore should not be evaluated purely on the basis of bioassays, but by proper chemical analysis of the products.
